The 12th Annual General Meeting ("AGM") of the Company will be held on Saturday, September 27, 2025 at 04:00 p.m. IST through Video Conferencing / Other Audio-Visual Means
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Lifeline Limited (BSE Scrip Code: 543616) has announced that its 12th Annual General Meeting will be held on Saturday, September 27, 2025 at 4:00 p.m. IST via Video Conferencing. The cut-off date to determine shareholder eligibility for e-voting is September 19, 2025, with remote e-voting open from September 24, 2025 (9:00 a.m.) to September 26, 2025 (5:00 p.m.). The company also submitted its Annual Report for FY 2024-25, highlighting strong financial performance: Total Revenue rose 51% YoY to ₹7,094 lakhs, EBITDA grew 87% to ₹2,066 lakhs, and PAT increased 85% to ₹1,305 lakhs, with EBITDA margin expanding from 24% to 29%. The company expanded its footprint through acquisitions including 51% stakes in TLL Parenterals (Dec 2024) and Trident Mediquip (Feb 2025), and commissioned subsidiary TNS Pharma's manufacturing facility. It now has 1,021 export products registered across 43 countries.
This is a routine AGM notice with a strong FY25 performance backdrop—revenue up 51%, profits nearly doubling, and margin expansion. Shareholders should review the notice for business items to be transacted and exercise e-voting between September 24-26, 2025. The robust growth and strategic acquisitions suggest positive momentum, though no specific price-moving announcement is included in this filing.